Clinical Trials on Delirium Symptoms in Australia

Total 7411 results

Medical University of Vienna

Completed

The Effect of Desflurane Versus Sevoflurane on Postoperative Recovery (RAPID)

Postoperative Delirium | Postoperative Recovery | Difference in Pharmakokinetics of Volatile Anesthetics

Austria
Medical University of Vienna

Completed

Cerebral Blood Supply During Cardiopulmonary Bypass

Postoperative Delirium

Austria
Medical University of Vienna

Recruiting

The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium (RAPID-II)

Postoperative Delirium | Postoperative Cognitive Dysfunction | Major Noncardiac Surgery

Austria
Central Coast Local Health District

Unknown

Prospective Randomised Controlled Trial of Delirium Management by Geriatric Medicine Versus General Medicine (CADIS)

Delirium

Australia
Austin Health
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation (DahLIA)

Delirium

Australia
University of Melbourne
Baxter Healthcare Corporation

Completed

Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane

Delirium | Coronary Artery Bypass | Dementia | Cognition Disorders | Morbidity | Amnesia

Australia
Bayside Health
Monash University

Recruiting

Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial (TRIGS-D)

Dementia | Surgical Site Infection | Cognition

Australia
Medical University of Graz

Not yet recruiting

Light and Noise: Objectively Assessing Environmental Risk Factors for Delirium in the ICU (LANYARD-ICU)

Delirium | Critical Illness

Austria
Medical University Innsbruck

Not yet recruiting

Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions (PAC-AIM)

Delirium | Heart Surgery | Vascular Surgery | Hyperinflammatory Syndrome

Austria
Louise Farrer

Withdrawn

Effectiveness of an Online Bulletin Board for Depression: a Longitudinal Randomized Controlled Trial (ShareIT)

Depression

Australia
Australian National University

Completed

IN2SHAPE: A Study of Physical Activity and Depressive Symptoms in Adolescence (IN2SHAPE)

Depression

Australia
Australian National University
University of Sydney; Commonwealth Scientific and Industrial Research Organisation... and other collaborators

Completed

Beyond Ageing Project: A Study for the Prevention of Depression

Depressive Disorder | Depression

Australia
Oslo University Hospital
St John of God Hospital, Vienna; Nepean Blue Mountains Local Health District

Completed

Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life (ENDO)

Quality of Life | Pain, Chronic | Deep Endometriosis | Bowel Dysfunction | Endometriosis Related Pain | Endometriosis Rectum | Deep Infiltrating Endometriosis

Norway, Australia, Austria
CSL Limited

Completed

Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients

Idiopathic Thrombocytopenic Purpura (ITP)

Australia
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Influenza

Australia, Singapore
Seqirus

Completed

Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years

Influenza

Australia
GlaxoSmithKline

Completed

Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination

Infections, Meningococcal

Australia
Azora Therapeutics Australia Pty Ltd

Completed

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa

Australia
Kirby Institute

Not yet recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

Hepatitis C

Australia
Kirby Institute
Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; Boehringer... and other collaborators

Completed

Can Resistance Enhance Selection of Treatment? (CREST)

HIV Infection

Australia
OliPass Australia Pty Ltd
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

Osteoarthritis

Australia
Cochlear

Recruiting

A Feasibility Study Evaluating the Performance of Focused Multipolar Stimulation in Adult Cochlear Implant Recipients (FOCUS)

Hearing Impairment

Australia
AstraZeneca

Completed

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

Heart Failure, Congestive

Australia
The University of Queensland

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients (BEAT-BK)

Kidney Transplant Infection | Kidney Transplant Failure and Rejection | BK Viremia

Australia
Merck KGaA, Darmstadt, Germany
Merck Serono Australia Pty Ltd

Completed

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (ReNew)

Multiple Sclerosis

Australia
Technovalia, Pty Ltd
Chulalongkorn University; Southern Star Research Pty Ltd.; BioNet-Asia

Active, not recruiting

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

COVID-19, SARS CoV 2 Infection

Australia
Varian, a Siemens Healthineers Company

Recruiting

HyperArc Registry Study

Brain Metastases | CNS Neoplasm | CNS Disorder, Intracranial

United States, Australia
Celtaxsys, Inc.
Clinical Network Services (CNS) Pty Ltd; Celtaxsys Aus Pty Limited

Completed

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

Acne Vulgaris

Australia, New Zealand
Medicines Development for Global Health

Completed

Dose-finding Study of Moxidectin for Treatment of Scabies

Scabies

Australia, Austria, France
480 Biomedical

Completed

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions (STANCE)

Atherosclerosis of Femoral Artery | Superficial Femoral Artery Lesions

New Zealand, Austria, Australia, Germany
CSL Limited

Completed

Subcutaneous Ig NextGen 16% in PID Patients

Primary Immunodeficiency (PID)

Australia, New Zealand
Incannex Healthcare Ltd

Recruiting

Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis (CHAPPII)

Rheumatoid Arthritis

Australia
Daré Bioscience, Inc.

Completed

Study of DARE-HRT1 Over 12 Weeks in Healthy PostMenopausal Women (DARE-HRT1)

Vasomotor Symptoms | Vulvovaginal Atrophy

Australia
Zeria Pharmaceutical

Completed

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Dyspepsia

Australia
Flinders University

Completed

Breathlessness Exertion and Morphine Sulphate (BEAMS)

Chronic Obstructive Pulmonary Disease | Dyspnea

Australia, New Zealand
Daré Bioscience, Inc.

Completed

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA (DARE-VVA1)

Vulvar Atrophy

Australia
Protalex, Inc.

Terminated

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Idiopathic Thrombocytopenic Purpura (ITP)

Australia, New Zealand
Telix International Pty Ltd

Completed

131I-IPA and Concurrent XRT in Recurrent GBM (IPAX-1)

Glioblastoma Multiforme

Austria, Australia, Netherlands
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 XG005-03 Topical Study

Pain

Australia
Chr Hansen

Completed

Effect of Two Probiotic Formulations on Mental Health and Mood Biomarkers in Adults With Depressive Symptoms

Depression, Anxiety

Australia
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Recruiting

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Bacterial Infections

Australia
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects

Bacterial Infections

Australia
Xgene Pharmaceutical Pty Ltd

Completed

Phase 1 Pharmacokinetics, Safety, and Tolerability Study

Pain

Australia
iX Biopharma Ltd.

Completed

Study of Ketamine Administered Intravenously and by Sublingual Wafer

Pain

Australia
Institut Franco Europeen de Chiropratique

Unknown

the Hypoalgesic Effect of Spinal Manual Therapy

Back Pain

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects

Bacterial Infections | Healthy Volunteers

Australia
Rempex Pharmaceuticals (a wholly owned subsidiary...

Completed

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

Bacterial Infections | Healthy Volunteers

Australia
Changchun GeneScience Pharmaceutical Co., Ltd.
Syneos Health

Recruiting

A Study to Assess Safety and Tolerability of GS1-144 in Healthy Volunteers

Vasomotor Symptoms | Adult Healthy Volunteers

Australia
Telethon Kids Institute

Recruiting

A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children (POPSICLE)

Chronic Pain

Australia
University of Adelaide
University of Sydney; Salk Institute for Biological Studies

Recruiting

Calories or Time Restriction to Alter Biomarkers of Aging and Diabetes (OMIT)

Obesity

Australia

Clinical Trials on Delirium Symptoms in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations